Eradication of Malignant Carcinoma in the Breast Tissue

Optimal Health Research60 enrolled

Overview

The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Breast Cancer

Interventions

AcetogeninsDIETARY_SUPPLEMENT

Acetogenins BID for 12 months

PlaceboDIETARY_SUPPLEMENT

Eligibility

Sex: FEMALEMin age: 35 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of breast cancer * Referred to the study by their treating physician Exclusion Criteria: * Any type of treatment for breast cancer before starting the study

Outcomes

Primary Outcomes

Number of participants tumor free

assessed by MRI

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.